cas 202062-80-4|| where to buy 4-(1,3-dioxolan-2-yl)piperidine

Produktname:4-(1,3-dioxolan-2-yl)piperidine

IUPAC Name:4-(1,3-dioxolan-2-yl)piperidine

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM743777-1g	in stock	ňƞ
CM743777-5g	in stock	ƞȀǕ
CM743777-10g	in stock	ňźǯ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 202062-80-4 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:202062-80-4; Molekulare Formel:C8H15NO2; Schmelzpunkt:-; SMILES-Code:C1COC(O1)C1CCNCC1; Dichte:

: Katalognummer:CM743777; Molekulargewicht:157.21; Siedepunkt:; Mdl-Nr.:MFCD16547635; Lagerung:

: Piperidines; Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.; Piperidine,Piperidine Price; if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

: Dioxolanes; Dioxolane is a heterocyclic acetal with the formula (CH2)2O2CH2. It is related to tetrahydrofuran by exchanging an oxygen for the CH2 group. The isomer 1,2-dioxolane (in which the two oxygen centers are adjacent) is a peroxide. 1,3-Dioxolane is used as solvent and comonomer in polyacetal. The dioxolane-type and their hydrogenolysis can provide very valuable partially protected building blocks either for oligosaccharide syntheses or sugar transformations.

: NX-5948; Nurix announced the presentation of the first findings of clinical responses in the brain for NX-5948. NX-5948 is an investigational, orally bioavailable, brain penetrant, small molecule degrader of BTK. NX-5948 is currently being evaluated in a Phase 1 clinical trial in patients with relapsed or refractory B cell malignancies.